We turn data into actionable clinical knowledge

Massachusetts General Hospital (MGH) Biostatistics includes over 50 faculty and staff who are deeply embedded in collaborative statistical methods and applied biomedical research. We work in diverse domains across over 25 Divisions and Departments at MGH and beyond. Our mission is to engage in impactful trans-disciplinary collaborations involving quantitative methods in public health and biomedicine.  

News & Events

MGH Biostatistics Launches Faculty Search 2024

Massachusetts General Hospital (MGH) Biostatistics is seeking qualified applicants with doctoral degrees in Biostatistics or a related field for a full-time faculty-level position in Biostatistics. Academic appointments at the rank

Brian Healy photo

Dr. Brian Healy publishes high-impact study regarding blast-related brain injury in active-duty US Special Operation Forces in PNAS

Dr. Brian Healy, PhD, Associate Investigator in Biostatistics at MGH and Associate Professor of Neurology at HMS, was the lead statistician for a paper published in the Proceedings of the National

Applied Biostatistics Seminar Series on Thu Sep 14: Designing a Longitudinal Clinical Trial Based on a Composite Endpoint: Sample Size, Monitoring, and Adaptation

Please join us for the tenth installment of the MGH Biostatistics Applied Biostatistics Seminar Series, a seminar series designed to introduce researchers to intermediate topics that are highly relevant to

Dr. Tanayott Thaweethai, Dr. Andrea S. Foulkes, and other members of MGH Biostatistics lead a JAMA paper defining long COVID

Tanayott Thaweethai, PhD, and Andrea S. Foulkes, ScD, alongside several other members of MGH Biostatistics including co-authors Caitlin A. Selvaggi, MS, Daniel J. Shinnick, MS, and Carolin Schulte, PhD, led a manuscript titled, “Development of a Definition of Postacute Sequelae of SARS-CoV-2 Infection,” published online in the Journal of the American Medical Association (JAMA) on May 25, 2023. This is a significant launching point for future research into understanding risk factors, mechanisms of disease, and potential therapies for long COVID.

Applied Biostatistics Seminar Series on Tue May 9: Does Real-World Evidence have a role in Precision Oncology?

Please join us for the next installment of the MGH Biostatistics Applied Biostatistics Seminar Series, a seminar series designed to introduce researchers to intermediate topics that are highly relevant to clinical

Applied Biostatistics Seminar Series on Thu Apr 20: Moving to a World Beyond p

Please join us for the next installment of the MGH Biostatistics Applied Biostatistics Seminar Series, a seminar series designed to introduce researchers to intermediate topics that are highly relevant to clinical

Applied Biostatistics Seminar Series on Thu Dec 1: Using stochastic-interventional causal effects to evaluate treatment efficacy in clinical trials (Nima Hejazi, PhD)

Please join us for the next installment of the MGH Biostatistics Applied Biostatistics Seminar Series, a seminar series designed to introduce researchers to intermediate topics that are highly relevant to clinical

MGH Biostatistics Launches Faculty Search 2022

The Massachusetts General Hospital (MGH) Division of Clinical Research is seeking qualified applicants with doctoral degrees in Biostatistics or a related field for a faculty-level position in Biostatistics.

Dr. Andrea Foulkes to Receive 2022 Lagakos Distinguished Alumni Award

Andrea S. Foulkes, ScD, director of Biostatistics at MGH, will be the recipient of the 2022 Lagakos Distinguished Alumni Award from the Department of Biostatistics at the Harvard T.H. Chan School of Public Health. This award recognizes Department alumni whose research in statistical theory and application, leadership in biomedical research, and commitment to teaching have had a major impact on the theory and practice of statistical science.

Mass General Brigham investigators approved for large studies on reversing acute suicidal depressed state, bipolar depression

A research team at MGH, led by Andrew A. Nierenberg, MD, director of the Dauten Family Center for Bipolar Treatment Innovation, and Andrea S. Foulkes, ScD, director of Biostatistics, has been approved for nearly $25 million in funding by the Patient-Centered Outcomes Research Institute (PCORI) to compare the effectiveness of four treatments for bipolar depression.